There is no content at this time. Please check back later.
COVID-19 Federal Responses: Thursday, December 23, 2021
Read the full articlePfizer says the two-dose COVID-19 vaccine regimen it tested on children did not consistently provide sufficient immune response in children between the ages two and five. However, the regimen was more effective for children between the ages of six months and two…
COVID-19 Federal Responses: Thursday, December 16, 2021
Read the full articleNew research shows that COVID-19 infection poses a greater risk of myocarditis than the vaccines. The CDC’s ACIP issued a new recommendation for the MRNA vaccines over the J&J vaccine, due to the blood clotting risks associated with the J&J…
COVID-19 Federal Responses: Monday, December 6, 2021
Read the full articleThe National Institutes of Allergy and Infectious Diseases (NIAID) Director Dr. Anthony Fauci said preliminary information about the Omicron variant shows it might not cause as severe disease as frequently as expected. However, more data is needed to confirm this information. Even though the…
COVID-19 Federal Responses: Thursday, December 2, 2021
Read the full articleWhite House COVID-19 Response Coordinator, Jeff Zients said the United States (U.S.) is not planning new lockdowns at this time despite many countries in Europe re-imposing lockdowns to combat new surges in COVID-19 infections. A new study shows that receiving…
COVID-19 Federal Responses: Thursday, November 18, 2021
Read the full articleThe Mayo Clinic reported that monoclonal antibodies reduced the risk of COVID-19 hospitalization by 77%. The Centers for Medicare and Medicaid Services (CMS) is offering individual clinicians an exemption from Merit-based Incentive Payment System (MIPS) reporting for 2021 due to hardships caused…
COVID-19 Federal Responses: Monday, November 15, 2021
Read the full articleAn appeals court opinion said the federal vaccine mandate for large employers is flawed. This legal challenge temporarily stops the mandate from taking effect while the legal challenge plays out. However, the mandate does not take effect until January 4. The Biden Administration announced…
COVID-19 Federal Responses: Monday, October 18, 2021
Read the full articleBeginning next week, states can order COVID-19 vaccines in preparation for efforts to vaccinate children ages 5-11. The FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) unanimously voted to recommend Emergency Use Authorization (EUA) of the Johnson & Johnson booster vaccine…
COVID-19 Federal Responses: Monday, October 4, 2021
Read the full articleThe European Medicines Agency (EMA), the European Union's drug regulator, recently discovered a possible link between the Johnson & Johnson vaccine and rare blood clotting (venous thromboembolism). J&J will seek FDA authorization of their COVID-19 booster vaccine. An updated Kaiser Family Foundation…
COVID-19 Federal Responses: Monday, November 29, 2021
Read the full articleModerna, Pfizer and Johnson & Johnson announced that they have all begun working on Omicron-specific COVID-19 vaccine boosters that should be ready in early 2022. Omicron has not been detected in the U.S., although National Institute of Allergy and Infectious Diseases (NIAID…
May issue of Annals highlights atopic dermatitis
Read the full articleThe May issue of Annals is budding with outstanding manuscripts that will help you provide the best possible care for your patients. The theme of this month’s issue is atopic dermatitis, and we have included an excellent editorial by Dr. Donald Leung that…
Leadership advocates for allergists and our specialty
Read the full articleAfter a three-year hiatus, your Advocacy Council Strike Force has resumed in-person advocacy. Last week, the following College leaders visited Washington, DC, to meet with congressional leaders and policymakers to advocate for issues important to practicing allergists: Michael Blaiss, MD, FACAAI, executive…
COVID-19 Federal Responses: Monday, April 18, 2022
Read the full articleThe FDA granted emergency use authorization of a breath test that can detect COVID-19 infections within as little as three minutes and has a 0.7% rate of false positives. During COVID-19 the rate of children receiving routine immunizations including the measles…
It’s food allergy awareness week
Read the full articleIt’s Food Allergy Awareness Week! More than 32 million Americans have a serious and potentially life-threatening food allergy, and many College members see patients with this condition. The College has food allergy resources for our members. From toolkits to webinars, enhance your…
It’s Asthma and Allergy Awareness Month
Read the full articleMay is National Asthma and Allergy Awareness Month! It’s a great time to promote your special training as an allergist – and the College has just what you need. Also take time this month to explore the College’s member resources to help you…
Administering drugs/biologics in physicians’ offices
Read the full articleClaims for drugs/biologics should be billed using the HCPCS/CPT code that most accurately describes the drug. Information in this article concerns drug administration services provided in physicians’ offices. Under the Medicare program, the administration of the following drugs should be billed using…
Ohio doctor acquitted; why all physicians should care
Read the full articleLast month, William Husel, MD, was acquitted on all counts related to deaths from prescribing fentanyl in high doses to 14 terminally ill patients in one of the largest murder trials in the state of Ohio. It was noted that he prescribed doses for…
COVID-19 Federal Responses: Thursday, April 14, 2022
Read the full articleA statistical analysis of reported cases, hospital admissions, reported deaths, and seroprevalence estimates that 43.9% of the global population had been infected with SARS-CoV-2 at least once as of Nov 14, 2021. Nationwide, 86% of COVID cases in the week ending…
Advocacy Insider
Read the full articleThe specialty’s leading advocate, the Advocacy Council, is committed to bringing you news and insights on billing, coding and policy reform that directly affect your practice. Advocacy Insider, a recurring column in College Insider, keeps you in the loop. Contact us at AdvocacyCouncil…
There are no posts at this time. Please check back later.